Blue Biotechnology Market - Global Professional Analysis and Forecast to 2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The worldwide Blue Biotechnology market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.0% during the forecast period.

    This report presents the market size and development trends by detailing the Blue Biotechnology market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Blue Biotechnology market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Blue Biotechnology industry and will help you to build a panoramic view of the industrial development.

    Blue Biotechnology Market, By Type:

    • Enzymes

    • Pharma Products

    • Bulk Chemicals

    • Biopolymers

    Blue Biotechnology Market, By Application:

    • Bio-Engineering

    • Genomics

    • Vaccine Development

    • Drug Discovery

    • Others

    Some of the leading players are as follows:

    • Aker BioMarine

    • PICES

    • Nurture Aqua Technology

    • Sanosil Biotech

    • Shell Marine Products

    • Marinova

    • Sea Run Holdings

    • Cellgen Biologicals

    • GeoMarine Biotechnologies

    • GlycoMar

    • Donald Danforth Plant Science Center

    • Samudra Biopharma

    • PML Applications

    • New England Biolabs

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Blue Biotechnology Market: Technology Type Analysis

    • 4.1 Blue Biotechnology Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Blue Biotechnology Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Enzymes

      • 4.3.2 Pharma Products

      • 4.3.3 Bulk Chemicals

      • 4.3.4 Biopolymers

    5 Blue Biotechnology Market: Product Analysis

    • 5.1 Blue Biotechnology Product Market Share Analysis, 2018 & 2026

    • 5.2 Blue Biotechnology Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Blue Biotechnology Market: Application Analysis

    • 6.1 Blue Biotechnology Application Market Share Analysis, 2018 & 2026

    • 6.2 Blue Biotechnology Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Bio-Engineering

      • 6.3.2 Genomics

      • 6.3.3 Vaccine Development

      • 6.3.4 Drug Discovery

      • 6.3.5 Others

    7 Blue Biotechnology Market: Regional Analysis

    • 7.1 Blue Biotechnology Regional Market Share Analysis, 2018 & 2026

    • 7.2 Blue Biotechnology Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Aker BioMarine

      • 9.1.1 Aker BioMarine Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 PICES

      • 9.2.1 PICES Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Nurture Aqua Technology

      • 9.3.1 Nurture Aqua Technology Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Sanosil Biotech

      • 9.4.1 Sanosil Biotech Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Shell Marine Products

      • 9.5.1 Shell Marine Products Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Marinova

      • 9.6.1 Marinova Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 Sea Run Holdings

      • 9.7.1 Sea Run Holdings Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Cellgen Biologicals

      • 9.8.1 Cellgen Biologicals Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 GeoMarine Biotechnologies

      • 9.9.1 GeoMarine Biotechnologies Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 GlycoMar

      • 9.10.1 GlycoMar Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

    • 9.11 Donald Danforth Plant Science Center

      • 9.11.1 Donald Danforth Plant Science Center Company overview

      • 9.11.2 Financial performance

      • 9.11.3 Product benchmarking

      • 9.11.4 Strategic initiatives

      • 9.11.5 SWOT analysis

    • 9.12 Samudra Biopharma

      • 9.12.1 Samudra Biopharma Company overview

      • 9.12.2 Financial performance

      • 9.12.3 Product benchmarking

      • 9.12.4 Strategic initiatives

      • 9.12.5 SWOT analysis

    • 9.13 PML Applications

      • 9.13.1 PML Applications Company overview

      • 9.13.2 Financial performance

      • 9.13.3 Product benchmarking

      • 9.13.4 Strategic initiatives

      • 9.13.5 SWOT analysis

    • 9.14 New England Biolabs

      • 9.14.1 New England Biolabs Company overview

      • 9.14.2 Financial performance

      • 9.14.3 Product benchmarking

      • 9.14.4 Strategic initiatives

      • 9.14.5 SWOT analysis

     

    The List of Tables and Figures (Totals 110 Figures and 141 Tables)

    • Figure Enzymes Blue Biotechnology market, 2015 - 2026 (USD Million)

    • Figure Pharma Products Blue Biotechnology market, 2015 - 2026 (USD Million)

    • Figure Bulk Chemicals Blue Biotechnology market, 2015 - 2026 (USD Million)

    • Figure Biopolymers Blue Biotechnology market, 2015 - 2026 (USD Million)

    • Figure Bio-Engineering market, 2015 - 2026 (USD Million)

    • Figure Genomics market, 2015 - 2026 (USD Million)

    • Figure Vaccine Development market, 2015 - 2026 (USD Million)

    • Figure Drug Discovery market, 2015 - 2026 (USD Million)

    • Figure Others market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Blue Biotechnology market, by country, 2015 - 2026 (USD Million)

    • Table North America Blue Biotechnology market, by type, 2015 - 2026 (USD Million)

    • Table North America Blue Biotechnology market, by product, 2015 - 2026 (USD Million)

    • Table North America Blue Biotechnology market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Blue Biotechnology market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Blue Biotechnology market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Blue Biotechnology market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Blue Biotechnology market, by type, 2015 - 2026 (USD Million)

    • Table Canada Blue Biotechnology market, by product, 2015 - 2026 (USD Million)

    • Table Canada Blue Biotechnology market, by application, 2015 - 2026 (USD Million)

    • Table Europe Blue Biotechnology market, by country, 2015 - 2026 (USD Million)

    • Table Europe Blue Biotechnology market, by type, 2015 - 2026 (USD Million)

    • Table Europe Blue Biotechnology market, by product, 2015 - 2026 (USD Million)

    • Table Europe Blue Biotechnology market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Blue Biotechnology market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Blue Biotechnology market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Blue Biotechnology market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Blue Biotechnology market, by type, 2015 - 2026 (USD Million)

    • Table Germany Blue Biotechnology market, by product, 2015 - 2026 (USD Million)

    • Table Germany Blue Biotechnology market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Blue Biotechnology market, by type, 2015 - 2026 (USD Million)

    • Table France Blue Biotechnology market, by product, 2015 - 2026 (USD Million)

    • Table France Blue Biotechnology market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Blue Biotechnology market, by type, 2015 - 2026 (USD Million)

    • Table Italy Blue Biotechnology market, by product, 2015 - 2026 (USD Million)

    • Table Italy Blue Biotechnology market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Blue Biotechnology market, by type, 2015 - 2026 (USD Million)

    • Table Spain Blue Biotechnology market, by product, 2015 - 2026 (USD Million)

    • Table Spain Blue Biotechnology market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Blue Biotechnology market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Blue Biotechnology market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Blue Biotechnology market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Blue Biotechnology market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Blue Biotechnology market, by type, 2015 - 2026 (USD Million)

    • Table China Blue Biotechnology market, by product, 2015 - 2026 (USD Million)

    • Table China Blue Biotechnology market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Blue Biotechnology market, by type, 2015 - 2026 (USD Million)

    • Table Japan Blue Biotechnology market, by product, 2015 - 2026 (USD Million)

    • Table Japan Blue Biotechnology market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Blue Biotechnology market, by type, 2015 - 2026 (USD Million)

    • Table India Blue Biotechnology market, by product, 2015 - 2026 (USD Million)

    • Table India Blue Biotechnology market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Blue Biotechnology market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Blue Biotechnology market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Blue Biotechnology market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Blue Biotechnology market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Blue Biotechnology market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Blue Biotechnology market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Blue Biotechnology market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Blue Biotechnology market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Blue Biotechnology market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Blue Biotechnology market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Blue Biotechnology market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Blue Biotechnology market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Blue Biotechnology market, by application, 2015 - 2026 (USD Million)

    • Table MEA Blue Biotechnology market, by country, 2015 - 2026 (USD Million)

    • Table MEA Blue Biotechnology market, by type, 2015 - 2026 (USD Million)

    • Table MEA Blue Biotechnology market, by product, 2015 - 2026 (USD Million)

    • Table MEA Blue Biotechnology market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Blue Biotechnology market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Blue Biotechnology market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Blue Biotechnology market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Blue Biotechnology market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Blue Biotechnology market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Blue Biotechnology market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Aker BioMarine Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table PICES Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Nurture Aqua Technology Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Sanosil Biotech Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Shell Marine Products Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Marinova Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Sea Run Holdings Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Cellgen Biologicals Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table GeoMarine Biotechnologies Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table GlycoMar Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Donald Danforth Plant Science Center Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Samudra Biopharma Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table PML Applications Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table New England Biolabs Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.